Quick Answer
Neurogene Inc. reported Net Income Loss of -$90.35 million for the year ending 2025.
- Neurogene Inc. showed a decrease of -20.2% in Net Income Loss from 2024 to 2025.
- This data is from Neurogene Inc.'s annual report (Form 10-K), filed with the SEC on March 24, 2026.
- XBRL data for this metric is available from 2012 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2012 to 2025), Neurogene Inc.'s Net Income Loss has declined by 1,071.2%.
- Historical annual values: Fiscal year 2025: -$90.35 million | Fiscal year 2024: -$75.14 million | Fiscal year 2023: $13.65 million | Fiscal year 2023: -$36.32 million | Fiscal year 2022: -$55.19 million | Fiscal year 2021: -$60.69 million | Fiscal year 2020: -$33.28 million | Fiscal year 2019: -$69.44 million | Fiscal year 2018: -$31.59 million | Fiscal year 2017: -$50.18 million | Fiscal year 2016: -$37.00 million | Fiscal year 2015: -$21.86 million | Fiscal year 2014: -$24.03 million | Fiscal year 2013: -$8.73 million | Fiscal year 2012: -$7.71 million.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: